The move comes as weight-loss medications have garnered immense national attention and ignited a debate about access and demand for the drugs, which help people shave pounds
They are often given alongside FSH injections to stimulate sperm production in men with secondary hypogonadism, a condition where the testicles are healthy but arent getting enough hormonal signals
Learn more about tirzepatide side effects here
However, there was a substantial shift in craving frequency among smokers.The proportion of participants reporting rarely or never craving nicotine increased from 4.6% (18 participants) before GLP-1 use to 22.6% (88 participants) after GLP-1 use
If you want a deeper look at how GLP-1 medications support weight management, our guide on what GLP-1 support is and how it works is a helpful place to start
State Medicaid programs will also have access to these medications at these prices. CNBC reported on November 6, 2025, that Medicare will start covering obesity drugs for some patients for the first time starting mid-2026, a long-awaited move that could broaden the market for the medicines and spur more private insurers to cover them. A senior administration official explained the rationale to CNBC: We are constraining the access for patients that will benefit clinically from it, weve worked very hard to strike a balance between broad access that just makes sure to capture patients that will benefit clinically. Documentation of these qualifying conditions will be essential for coverage approval